That one is a viral vector vaccine – the gene that codes for the SARS-CoV-2 spike protein is carried inside a “shell” created from an adenovirus particle, which itself cannot replicate or ...

The largest COVID vaccine study to date has identified some risks associated with the shot. Researchers from the Global Vaccine Data Network (GVDN) in New Zealand analyzed 99 million people who ...

Crucially, this vector poses no threat to humans, enhancing the vaccine's safety profile. In 2022, researchers from the department Viral Immunology headed by Prof. Luka Cicin-Sain at the Helmholtz ...

Viral-vectored vaccines can be designed quickly. One concern is that people can develop immunity to the viral vector, making this approach potentially less useful if booster shots need to be given.

Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models. Nature Communications , 2025; 16 (1) DOI: 10.1038/s41467-025-58504-z ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional ...

the animals were primed with a vesicular stomatitis virus (VSV) as a vaccine delivery mechanism. VSV represents a promising vector approach across vaccine research. However, in contrast to ...